Overview

Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease

Status:
Completed
Trial end date:
2017-12-19
Target enrollment:
Participant gender:
Summary
FOS improve gut colonization by Faecalibacterium prausnitzii in patients with Crohn's disease
Phase:
N/A
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborator:
AbbVie
Treatments:
Adalimumab